Exploration of the Optimal Dosage of Cetirizine in the Treatment of Allergic Diseases in Chinese Children
Phase 4
Recruiting
- Conditions
- ChildrenAllergic Disease
- Interventions
- Other: 1-3 Cetirizine Pharmacokinetic samples
- First Posted Date
- 2024-03-01
- Last Posted Date
- 2024-03-01
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT06288334
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China
Analysis of Prognosis and Risk Factors of LAL Reconstruction Procedure for Patients With AF of the LAL: a Prospective Cohort Study
Active, not recruiting
- Conditions
- Avulsion Fracture of Lateral Ankle Ligament
- Interventions
- Procedure: lateral ankle ligament repair or reconstruction
- First Posted Date
- 2024-02-26
- Last Posted Date
- 2024-02-26
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 120
- Registration Number
- NCT06277544
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, China
Evaluation of diagnostiC Capacity of eccDNAs as Biomarkers in Indetermined biLiary Stricture(ECCBILE)
Recruiting
- Conditions
- Biliary StrictureBile Duct CancerPancreas Cancer
- First Posted Date
- 2024-02-26
- Last Posted Date
- 2024-07-29
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 99
- Registration Number
- NCT06277531
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China
🇨🇳Beijing Tsinghua Changgung Hospital, Beijing, Beijing, China
A Prospective Multicenter Cohort Study About Internal Fixation Using PFUN Versus PFNA for Femoral Intertrochanteric Fracture
Not Applicable
Recruiting
- Conditions
- Femoral Intertrochanteric Fractures
- Interventions
- Device: PFNADevice: PFUN
- First Posted Date
- 2024-02-26
- Last Posted Date
- 2024-02-26
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 130
- Registration Number
- NCT06277622
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China
Evaluation of the Pharmacokinetics of Microdose Midazolam, Dabigatran, Pitavastatin, Atorvastatin and Rosuvastatin in Diabetic Patients
Phase 4
Recruiting
- Conditions
- Diabetes
- Interventions
- Drug: The combinations of 10 µg midazolam, 375 µg dabigatran etexilate, 10 µg pitavastatin, 50 µg rosuvastatin, and 100 µg atorvastatin were administered to diabetic patients on an empty stomach.
- First Posted Date
- 2024-02-22
- Last Posted Date
- 2024-02-22
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 48
- Registration Number
- NCT06273215
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China
Multi-center Study on Comprehensive Diagnosis and Treatment of Lower Limb Bone Defect Based on Three-dimensional Printing Technology
Recruiting
- Conditions
- Bone Defects
- Interventions
- Device: 3D printed prostheses
- First Posted Date
- 2024-02-21
- Last Posted Date
- 2024-02-21
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 120
- Registration Number
- NCT06269354
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, Haidian, China
Motor Function Assessment System Based on Video Tracking and Artificial Intelligence Technique
Not Applicable
Completed
- Conditions
- Cervical Spine Myelopathy
- Interventions
- Diagnostic Test: Motor Function Assessment System
- First Posted Date
- 2024-02-05
- Last Posted Date
- 2024-02-05
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 72
- Registration Number
- NCT06242054
- Locations
- 🇨🇳
Feifei Zhou, Beijing, Beijing, China
A Study on Diagnosis and Treatment Strategies for Atlantoaxial Dislocation
Recruiting
- Conditions
- Atlantoaxial DislocationTreatmentDiagnostic
- Interventions
- Other: Observational research without intervention
- First Posted Date
- 2024-01-31
- Last Posted Date
- 2024-04-03
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 3000
- Registration Number
- NCT06233539
- Locations
- 🇨🇳
Shenglin Wang, Beijing, Beijing, China
Multi-center Clinical Observation and Mechanism Study of Yunnan Baiyao in Different Stages of Diabetic Foot Ulcer
Phase 4
Recruiting
- Conditions
- Diabetic Foot Ulcer Treatment
- Interventions
- Drug: Yunnan Baiyao
- First Posted Date
- 2024-01-09
- Last Posted Date
- 2024-07-03
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT06197412
- Locations
- 🇨🇳
Peking University 3rd Hospital, Beijing, China
CT-guided Radioactive Iodine-125 Seed Implantation for Recurrent Desmoid Tumors
Completed
- Conditions
- BrachytherapyDesmoid TumorRadioactive Iodine-125 Seed Implantation
- Interventions
- Radiation: CT-guided radioactive iodine-125 seed implantation
- First Posted Date
- 2024-01-08
- Last Posted Date
- 2024-01-08
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 38
- Registration Number
- NCT06195085
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China
© Copyright 2025. All Rights Reserved by MedPath